Wednesday, December 23, 2009

Increased awareness of mesothelioma and other asbestos-caused diseases has led to an increase on medical research to cure and control asbestos-caused cancers and related asbestos heart and respiratory diseases. Drugs produce a medical benefit by themselves, and they can produce a different benefit when combined with other drugs – a chemical reaction that produces a third result.

Mesothelioma clinical trials with Gemcitabine proved Gemcitabine to be ineffective. However, mesothelioma clinical trials using Cisplatin and Gemcitabine together are proving to be even more promising. Mesothelioma treatment and treatment options for advanced malignant mesothelioma are not limited to surgery and chemotherapy.

Advanced malignant mesothelioma patients have a higher vascular endothelial growth factor than patients with other cancers. Anti-angiogenic therapies focus on natural body substances that affect the mesothelioma cancer’s growth.

Read More

0 Comments:

Post a Comment